Trial intelligence / Profile preview

TOGETHER: Caduet vs Guideline-Based Approach in Hypertension and Dyslipidemia

NCT00412113Phase 4Completed

Sponsor
Viatris
Start
Jan 2007
Primary completion
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amlodipine in hypertension (HTN), dyslipidemia, sponsored by Viatris. Started Jan 2007; status: completed.

02

Drugs

amlodipine
03

Conditions

hypertension (HTN)dyslipidemia

Beyond the preview

Go deeper on NCT00412113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00412113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call